Leadership
Experienced pharmaceutical executives with multinational track records, deep regulatory knowledge, and proven African market expertise.
Founder
Pharmaceutical strategy, corporate finance, and transaction execution. Leading Ansilo's vision of building an integrated pharmaceutical company for Africa. Dr Klein brings deep experience in pharmaceutical business building, capital raising, and strategic partnerships.
General Manager
Pharmaceutical operations and country management with extensive P&L leadership experience. Peane has deep expertise in building and managing pharmaceutical commercial operations across African markets.
Chief Financial Officer
Financial strategy, DFI engagement, and corporate governance. Dan brings expertise in capital raising, financial reporting, institutional investor relations, and financial risk management.
Chief Commercial Officer
Commercial strategy, brand management, and pharmaceutical sales leadership. Dr Geraty has a proven track record of building successful commercial organisations and launching pharmaceutical products.
Chief Regulatory Officer
SAHPRA submissions, regulatory compliance, and GMP auditing. Ilse brings deep pharmaceutical regulatory affairs expertise and a strong track record in quality systems implementation.
Medical Director
Clinical governance, medical affairs, and healthcare professional engagement. Dr Nkadimeng brings expertise in pharmaceutical medical management, patient safety, and clinical governance frameworks.
Chief Supply Chain Officer
Pharmaceutical logistics, 3PL management, and supply chain operations. Shahista has deep expertise in building resilient pharmaceutical supply chains and managing complex logistics networks.
Operations Manager
Facility operations, production planning, and operational execution. Vincent brings experience in pharmaceutical manufacturing operations, quality management, and process optimisation.
Founder's Vision
Why Ansilo exists, why African pharmaceutical capability matters, and the long-term ambition.
“Our goal is to build one of Africa's most important pharmaceutical companies — serving patients, creating value for partners and investors, and demonstrating that world-class pharmaceutical capability can be built on this continent. This is not a short-term venture. It is a long-term commitment to African healthcare.”
Dr Michael Klein
Founder, Ansilo Health
Our Values
The principles that guide our decisions and define our culture.
Patient safety and product quality are non-negotiable. Every decision is measured against its impact on the quality of care patients receive.
We operate to the highest pharmaceutical regulatory standards, building systems and culture that exceed compliance requirements.
We do what we say. Our phased approach ensures we build capability sustainably, delivering on commitments to partners and stakeholders.
We are built for Africa, by people who understand the continent. Our success is measured by our contribution to African healthcare.
